Evidence map›Paper›PMID 34851157›Full record

ArticleMicrobiology spectrum2021

Dose Optimization of Combined Linezolid and Fosfomycin against

Jun Mao, Ting Li, Na Zhang, Shuaishuai Wang, Yaowen Li, Yu Peng, Huiping Liu, Guang Yang, Yisong Yan, Lifang Jiang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. NParasitology · 2024
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Jun Mao *Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Ting Li *Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicinegrid.412540.6, Shanghai, China.
Na ZhangDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Shuaishuai WangDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Yaowen LiDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Yu PengDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Huiping LiuDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Guang YangDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Yisong YanDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Lifang JiangDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.
Yanyan LiuDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical Universitygrid.186775.a, Hefei, China.
Jiabin LiDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical Universitygrid.186775.a, Hefei, China.
Xiaohui HuangDepartment of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical Universitygrid.186775.a, Hefei, China.ORCID 0000-0002-4768-9103
Anhui Medical University · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid spread of antibiotic resistance among

Indexed as

Anti-Bacterial AgentsCross InfectionDrug Resistance, BacterialDrug SynergismEnterococcusFosfomycinGram-Positive Bacterial InfectionsHumansLinezolidMicrobial Sensitivity TestsAnti-Bacterial AgentsFosfomycinLinezolidcombination therapyEnterococcusfosfomycinlinezolidPK/PD model

Identifiers

PMID34851157
PMCPMC8635129
OpenAlexW3216396537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.